ClinConnect ClinConnect Logo
Search / Trial NCT02602093

Percutaneous Transforaminal Endoscopic Discectomy vs. Open Microdiscectomy for Lumbar Disc Herniation (PTED-study)

Launched by AMSTERDAM UMC, LOCATION VUMC · Nov 9, 2015

Trial Information

Current as of May 29, 2025

Unknown status

Keywords

Lumbar Disk Herniation Percutaneous Transforaminal Endoscopic Discectomy Micro Discectomy Minimal Invasive Spine Surgery

ClinConnect Summary

Rationale: Lumbosacral radicular syndrome (LSRS) is caused by a herniated lumbar nucleus pulposus (HNP) and the estimated annual incidence in The Netherlands ranges between 60,000 to 75,000 people. Open microdiscectomy is the standard surgical technique.

In recent years, several surgical techniques have been developed including, percutaneous transforaminal endoscopic discectomy (PTED). While PTED is gaining popularity in The Netherlands, evidence of its effects is lacking, leading to a heated debate. The current position of Zorginstituut Nederland (ZiN) is that there is insufficient eviden...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 10 weeks of radiating pain with- or without motor or sensory loss in the leg, or with \> 6weeks of excessive radiating pain and no tendency for any clinical improvement and strong patient preference for surgery;
  • Indication for an operation according to consensus;
  • MRI demonstrating lumbar disc herniation with nerve compression with or without concomitant spinal or lateral recess stenosis or sequestration;
  • Sufficient knowledge of the Dutch language in order to complete forms and follow instructions independently.
  • Exclusion Criteria:
  • Previous surgery on the same or adjacent disc level;
  • Cauda equina syndrome (CES);
  • Spondylytic or degenerative spondylolisthesis;
  • Pregnancy;
  • Severe comorbid medical or psychiatric disorder (ASA\>2);
  • Severe caudal or cranial sequestration;
  • Moving abroad at short notice

About Amsterdam Umc, Location Vumc

Amsterdam UMC, located at VU Medical Center (VUmc), is a leading academic medical center in the Netherlands dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on translating scientific discoveries into practical applications, Amsterdam UMC collaborates closely with researchers, healthcare professionals, and industry partners to enhance patient outcomes. The institution is committed to rigorous ethical standards and regulatory compliance, ensuring the integrity and reliability of its clinical research initiatives across various medical disciplines.

Locations

Rotterdam, Zuid Holland, Netherlands

Patients applied

0 patients applied

Trial Officials

Biswadjiet Harhangi, MD, PhD

Study Director

Erasmus Medical Center

Sidney Rubinstein, PhD

Principal Investigator

VU

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials